{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T12:38:15Z","timestamp":1785587895154,"version":"3.56.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s40273-019-00775-8","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T01:30:50Z","timestamp":1550539850000},"page":"921-929","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Estimating Quality of Life Decrements Due to Diabetes Complications in the United States: The Health Utility Index (HUI) Diabetes Complication Equation"],"prefix":"10.1007","volume":"37","author":[{"given":"Hui","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Stoecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"775_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/bmb\/ldq033","volume":"96","author":"SJ Whitehead","year":"2010","unstructured":"Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96:5\u201321.","journal-title":"Br Med Bull"},{"key":"775_CR2","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1287\/opre.18.6.1021","volume":"18","author":"S Fanshel","year":"1970","unstructured":"Fanshel S, Bush JW. A health-status index and its application to health-services outcomes. Oper Res. 1970;18:1021\u201366.","journal-title":"Oper Res"},{"key":"775_CR3","first-page":"118","volume":"7","author":"GW Torrance","year":"1972","unstructured":"Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res. 1972;7:118.","journal-title":"Health Serv Res"},{"key":"775_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1056\/NEJM197703312961304","volume":"296","author":"MC Weinstein","year":"1977","unstructured":"Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716\u201321.","journal-title":"N Engl J Med"},{"key":"775_CR5","doi-asserted-by":"crossref","unstructured":"Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ 2004;329:224.","DOI":"10.1136\/bmj.329.7459.224"},{"key":"775_CR6","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-effectiveness in health and medicine","author":"MR Gold","year":"1996","unstructured":"Gold MR. Cost-effectiveness in health and medicine. Oxford: Oxford University Press; 1996."},{"key":"775_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/heapol\/czl018","volume":"21","author":"F Sassi","year":"2006","unstructured":"Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health policy and planning. 2006;21:402\u20138.","journal-title":"Health policy and planning"},{"key":"775_CR8","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2015."},{"key":"775_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/070674370505000305","volume":"50","author":"JS Hoch","year":"2005","unstructured":"Hoch JS, Dewa CS. An introduction to economic evaluation: what\u2019s in a name? Can J Psychiatry. 2005;50:159\u201366.","journal-title":"Can J Psychiatry"},{"key":"775_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40273-017-0537-x","volume":"35","author":"J Karnon","year":"2017","unstructured":"Karnon J. Heath state utility values for cost-effectiveness models. PharmacoEconomics. 2017;35:1\u20133.","journal-title":"PharmacoEconomics"},{"key":"775_CR11","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1111\/j.1524-4733.2009.00515.x","volume":"12","author":"MC Weinstein","year":"2009","unstructured":"Weinstein MC, Torrance G, McGuire A. QALYs: the basics. Value Health. 2009;12:S5\u20139.","journal-title":"Value Health"},{"key":"775_CR12","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1111\/j.1524-4733.2009.00516.x","volume":"12","author":"E Nord","year":"2009","unstructured":"Nord E, Daniels N, Kamlet M. QALYs: some challenges. Value Health. 2009;12:S10\u20135.","journal-title":"Value Health"},{"key":"775_CR13","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1111\/j.1524-4733.2009.00519.x","volume":"12","author":"P Kind","year":"2009","unstructured":"Kind P, Lafata JE, Matuszewski K, Raisch D. The use of QALYs in clinical and patient decision-making: issues and prospects. Value Health. 2009;12:S27\u201330.","journal-title":"Value Health"},{"key":"775_CR14","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095\u2013108.","journal-title":"Med Care"},{"key":"775_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00005650-200202000-00006","volume":"40","author":"D Feeny","year":"2002","unstructured":"Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40:113\u201328.","journal-title":"Med Care"},{"key":"775_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271\u201392.","journal-title":"J Health Econ"},{"key":"775_CR17","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1097\/01.mlr.0000254567.79743.e2","volume":"45","author":"DA DeWalt","year":"2007","unstructured":"DeWalt DA, Rothrock N, Yount S, Stone AA. Evaluation of item candidates: the PROMIS qualitative item review. Med Care. 2007;45:S12.","journal-title":"Med Care"},{"key":"775_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40273-017-0551-z","volume":"35","author":"R Ara","year":"2017","unstructured":"Ara R, Brazier J. Estimating health state utility values for comorbidities. PharmacoEconomics. 2017;35:89\u201394.","journal-title":"PharmacoEconomics"},{"key":"775_CR19","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.2337\/diacare.25.12.2238","volume":"25","author":"JT Coffey","year":"2002","unstructured":"Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, Engelgau MM, Kaplan RM, Herman WH. Valuing health-related quality of life in diabetes. Diabetes Care. 2002;25:2238\u201343.","journal-title":"Diabetes Care"},{"key":"775_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/027298902400448902","volume":"22","author":"P Clarke","year":"2002","unstructured":"Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Mak. 2002;22:340\u20139.","journal-title":"Med Decis Mak"},{"key":"775_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2337\/diacare.25.3.458","volume":"25","author":"WK Redekop","year":"2002","unstructured":"Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25:458\u201363.","journal-title":"Diabetes Care"},{"key":"775_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/hec.910","volume":"14","author":"A Bagust","year":"2005","unstructured":"Bagust A, Beale S. Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Econ. 2005;14:217\u201330.","journal-title":"Health Econ"},{"key":"775_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1477-7525-5-21","volume":"5","author":"P Glasziou","year":"2007","unstructured":"Glasziou P, Alexander J, Beller E, Clarke P. Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes. 2007;5:21.","journal-title":"Health Qual Life Outcomes"},{"key":"775_CR24","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.2337\/dc11-2478","volume":"35","author":"P Zhang","year":"2012","unstructured":"Zhang P, Brown MB, Bilik D, Ackermann RT, Li R, Herman WH. Health utility scores for people with type 2 diabetes in US managed care health plans. Diabetes Care. 2012;35:2250\u20136.","journal-title":"Diabetes Care"},{"key":"775_CR25","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s11136-011-9902-y","volume":"20","author":"TW Lung","year":"2011","unstructured":"Lung TW, Hayes AJ, Hayen A, Farmer A, Clarke PM. A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation. Qual Life Res. 2011;20:1669\u201378.","journal-title":"Qual Life Res"},{"key":"775_CR26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1365-2265.2012.04480.x","volume":"78","author":"K Venkataraman","year":"2013","unstructured":"Venkataraman K, Wee H, Leow M, Tai E, Lee J, Lim S, Tavintharan S, Wong T, Ma S, Heng D. Associations between complications and health-related quality of life in individuals with diabetes. Clin Endocrinol. 2013;78:865\u201373.","journal-title":"Clin Endocrinol"},{"key":"775_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hec.2930","volume":"23","author":"M Alva","year":"2014","unstructured":"Alva M, Gray A, Mihaylova B, Clarke P. The effect of diabetes complications on health-related quality of life: the importance of longitudinal data to address patient heterogeneity. Health Econ. 2014;23:487\u2013500.","journal-title":"Health Econ"},{"key":"775_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jval.2015.10.010","volume":"19","author":"A Hayes","year":"2016","unstructured":"Hayes A, Arima H, Woodward M, Chalmers J, Poulter N, Hamet P, Clarke P. Changes in quality of life associated with complications of diabetes: results from the ADVANCE study. Value Health. 2016;19:36\u201341.","journal-title":"Value Health"},{"key":"775_CR29","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.2337\/dc11-2478","volume":"35","author":"P Zhang","year":"2012","unstructured":"Zhang P, Brown MB, Bilik D, Ackermann RT, Li R, Herman WH. Health utility scores for people with type 2 diabetes in US managed care health plans: results from Translating Research Into Action for Diabetes (TRIAD). Diabetes Care. 2012;35:2250\u20136.","journal-title":"Diabetes Care"},{"key":"775_CR30","doi-asserted-by":"crossref","unstructured":"Pesantes MA, Brandt LR, Ipince A, Miranda JJ, Diez-Canseco F. An exploration into caring for a stroke-survivor in Lima, Peru: emotional impact, stress factors, coping mechanisms and unmet needs of informal caregivers. eNeurologicalSci. 2017;6:33\u201350.","DOI":"10.1016\/j.ensci.2016.11.004"},{"key":"775_CR31","unstructured":"Lewis EF, Li Y, Pfeffer MA, Solomon SD, Weinfurt KP, Velazquez EJ, Califf RM, Rouleau J-L, Kober L, White HD. Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction). JACC: Heart Fail. 2014;2:159\u2013165."},{"key":"775_CR32","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.amjcard.2007.03.003","volume":"99","author":"JB Buse","year":"2007","unstructured":"Buse JB, Group AS. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol. 2007;99:S21\u201333.","journal-title":"Am J Cardiol"},{"key":"775_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","volume":"376","author":"F Ismail-Beigi","year":"2010","unstructured":"Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O\u2019Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376:419\u201330.","journal-title":"Lancet"},{"key":"775_CR34","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/j.amjcard.2007.03.025","volume":"99","author":"C Kingry","year":"2007","unstructured":"Kingry C, Bastien A, Booth G, Geraci TS, Kirpach BR, Lovato LC, Margolis KL, Rosenberg Y, Sperl-Hillen JM, Vargo L. Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007;99:S68\u201379.","journal-title":"Am J Cardiol"},{"key":"775_CR35","doi-asserted-by":"crossref","unstructured":"Baser OH, Li L, Wang L. Obese patients in the veteran population in the united states: a health care cost and utilization analysis. Value Health. 2013;16(3):A110.","DOI":"10.1016\/j.jval.2013.03.526"},{"key":"775_CR36","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1016\/j.amjcard.2007.03.027","volume":"99","author":"MD Sullivan","year":"2007","unstructured":"Sullivan MD, Anderson RT, Aron D, Atkinson HH, Bastien A, Chen GJ, Feeney P, Gafni A, Hwang W, Katz LA, Venkat Narayan KM, Nwachuku C, O\u2019Connor PJ, Zhang P. Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: rationale and design. Am J Cardiol. 2007;99:S90\u2013102.","journal-title":"Am J Cardiol"},{"key":"775_CR37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1477-7525-1-54","volume":"1","author":"J Horsman","year":"2003","unstructured":"Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI\u00ae): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1:54.","journal-title":"Health Qual Life Outcomes"},{"key":"775_CR38","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1185\/030079904X1980","volume":"20","author":"AJ Palmer","year":"2004","unstructured":"Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, Lurati FM, Lammert M, Spinas GA. The CORE Diabetes Model: projecting long-term clinical outcomes, costs and costeffectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin. 2004;20:S5\u201326.","journal-title":"Curr Med Res Opin"},{"key":"775_CR39","unstructured":"RTI Press. Validation of the CDC-RTI diabetes cost-effectiveness model [article online]. 2009. Available from https:\/\/www.rti.org\/ . Accessed 15 May 2018."},{"key":"775_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12955-014-0167-3","volume":"12","author":"L Shi","year":"2014","unstructured":"Shi L, Shao H, Zhao Y, Thomas NA. Is hypoglycemia fear independently associated with health-related quality of life? Health Qual Life Outcomes. 2014;12:167.","journal-title":"Health Qual Life Outcomes"},{"key":"775_CR41","doi-asserted-by":"crossref","unstructured":"Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care. 2005;43:1078\u201386.","DOI":"10.1097\/01.mlr.0000182493.57090.c1"},{"key":"775_CR42","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2165\/00019053-199813040-00005","volume":"13","author":"JA Johnson","year":"1998","unstructured":"Johnson JA, Coons SJ, Ergo A, Szava-Kovats G. Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics. 1998;13:421\u201333.","journal-title":"Pharmacoeconomics"},{"key":"775_CR43","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00005650-200503000-00004","volume":"43","author":"JA Johnson","year":"2005","unstructured":"Johnson JA, Luo N, Shaw JW, Kind P, Coons SJ. Valuations of EQ-5D health states: are the United States and United Kingdom different? Med Care. 2005;43:221\u20138.","journal-title":"Med Care"},{"key":"775_CR44","unstructured":"Action to Control Cardiovascular Risk in Diabetes (ACCORD) data [article online]. Available from https:\/\/biolincc.nhlbi.nih.gov\/studies\/accord\/ . Accessed 15 Ma 2018."}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40273-019-00775-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-019-00775-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-019-00775-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T21:54:08Z","timestamp":1720994048000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40273-019-00775-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,19]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["775"],"URL":"https:\/\/doi.org\/10.1007\/s40273-019-00775-8","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,19]]},"assertion":[{"value":"19 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors, including Hui Shao, Shuang Yang, Vivian Fonseca, Charles Stoecker, and Lizheng Shi disclosed no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The datasets used for this study are publicly available and can be accessed through the National Heart, Lung, and Blood Institute [].","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}}]}}